Compare JD.Com Inc (JD) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
JD.Com Inc vs Zoetis Inc — how do they compare? JD.Com Inc trades at $27.09 (market cap $36.62B), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: JD.Com Inc is the larger of the two by market cap, and JD.Com Inc pays the higher dividend (3.72%). Which is the better fit depends on your goals — on Pluang, investors hold JD.Com Inc for 85 Days and Zoetis Inc for 70 Days on average.
| JD | ZTS | |
|---|---|---|
Market Cap | $36.62B | $30.20B |
Volume | 6,571,477 | 6,175,327 |
Sector | Consumer Cyclical | Health |
52-Week High | $34.53 | $147.53 |
52-Week Low | $25.19 | $69.09 |
Typical Hold Time | 85 Days | 70 Days |
Enterprise Value | $19.26B | $37.76B |
Dividend Yield | 3.72% | 2.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
JD.com (JD) trades at $26.91, down 0.44% on the day, amid mixed technical signals but strong fundamental value. The stock shows a bullish overall technical signal despite bearish moving averages, with key support at $26. Valuation metrics are attractive with a P/E of 17.9 and P/S of 0.2, while recent earnings beats and a pending Q3 report highlight operational strength. Positive news includes potential EU approval for the $2.5 billion Ceconomy acquisition (Reuters, 2026-10-02).
The outlook remains favorable given deep undervaluation, robust cash flow, and analyst consensus pointing to 33% upside to the $35.86 price target. Risks include revenue growth deceleration, regulatory scrutiny from EU probes, and macroeconomic pressures on Chinese equities. The stock's net cash position and institutional accumulation support a constructive view for long-term investors.
Zoetis (ZTS) trades at $74.77, up 4.5% with strong profitability metrics including 71.67% gross margins and 27.69% net income margin. The stock shows mixed technical signals with bullish oscillators but bearish moving averages, trading near resistance at $75. Recent earnings show beats in Q4 2025 and Q2 2026 but a miss in Q1 2026, with Q3 2026 results pending. The company maintains robust cash flow generation despite competitive pressures in the U.S. companion animal market.
Zoetis presents a compelling value opportunity with a P/E of 11.92 below industry averages, though near-term headwinds from pet care weakness and competition persist. Analyst consensus targets $87.33 with no sell ratings, suggesting 17% upside potential. Key risks include ongoing margin pressure and market share challenges, but strong international growth and dividend sustainability support long-term bullish thesis.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About JD.Com Inc
JD.com is China's second-largest e-commerce company after Alibaba in terms of gross merchandise volume, offering a wide selection of authentic products at competitive prices, with speedy and reliable delivery. The company has built its own nationwide fulfilment infrastructure and last-mile delivery network, staffed by its own employees, which supports both its online direct sales, its online marketplace and omnichannel businesses.
Read more on JD →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
